BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24958103)

  • 1. Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease.
    Kurbegovic A; Kim H; Xu H; Yu S; Cruanès J; Maser RL; Boletta A; Trudel M; Qian F
    Mol Cell Biol; 2014 Sep; 34(17):3341-53. PubMed ID: 24958103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystin-1 surface localization is stimulated by polycystin-2 and cleavage at the G protein-coupled receptor proteolytic site.
    Chapin HC; Rajendran V; Caplan MJ
    Mol Biol Cell; 2010 Dec; 21(24):4338-48. PubMed ID: 20980620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity.
    Fedeles SV; So JS; Shrikhande A; Lee SH; Gallagher AR; Barkauskas CE; Somlo S; Lee AH
    J Clin Invest; 2015 May; 125(5):1955-67. PubMed ID: 25844898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a polycystin-1 cleavage product, P100, that regulates store operated Ca entry through interactions with STIM1.
    Woodward OM; Li Y; Yu S; Greenwell P; Wodarczyk C; Boletta A; Guggino WB; Qian F
    PLoS One; 2010 Aug; 5(8):e12305. PubMed ID: 20808796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered trafficking and stability of polycystins underlie polycystic kidney disease.
    Cai Y; Fedeles SV; Dong K; Anyatonwu G; Onoe T; Mitobe M; Gao JD; Okuhara D; Tian X; Gallagher AR; Tang Z; Xie X; Lalioti MD; Lee AH; Ehrlich BE; Somlo S
    J Clin Invest; 2014 Dec; 124(12):5129-44. PubMed ID: 25365220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
    Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
    J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of polycystin expression, maturation and trafficking.
    Hu J; Harris PC
    Cell Signal; 2020 Aug; 72():109630. PubMed ID: 32275942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polycystin-1 regulates STAT activity by a dual mechanism.
    Talbot JJ; Shillingford JM; Vasanth S; Doerr N; Mukherjee S; Kinter MT; Watnick T; Weimbs T
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7985-90. PubMed ID: 21518865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of polycystin-1 ciliary trafficking by motifs at its C-terminus and polycystin-2 but not by cleavage at the GPS site.
    Su X; Wu M; Yao G; El-Jouni W; Luo C; Tabari A; Zhou J
    J Cell Sci; 2015 Nov; 128(22):4063-73. PubMed ID: 26430213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure.
    Yu S; Hackmann K; Gao J; He X; Piontek K; García-González MA; Menezes LF; Xu H; Germino GG; Zuo J; Qian F
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18688-93. PubMed ID: 18003909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage fragments of the C-terminal tail of polycystin-1 are regulated by oxidative stress and induce mitochondrial dysfunction.
    Pellegrini H; Sharpe EH; Liu G; Nishiuchi E; Doerr N; Kipp KR; Chin T; Schimmel MF; Weimbs T
    J Biol Chem; 2023 Sep; 299(9):105158. PubMed ID: 37579949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling.
    Lal M; Song X; Pluznick JL; Di Giovanni V; Merrick DM; Rosenblum ND; Chauvet V; Gottardi CJ; Pei Y; Caplan MJ
    Hum Mol Genet; 2008 Oct; 17(20):3105-17. PubMed ID: 18632682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cis-autoproteolysis of polycystin-1, the product of human polycystic kidney disease 1 gene.
    Wei W; Hackmann K; Xu H; Germino G; Qian F
    J Biol Chem; 2007 Jul; 282(30):21729-37. PubMed ID: 17525154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystin-1 negatively regulates Polycystin-2 expression via the aggresome/autophagosome pathway.
    Cebotaru V; Cebotaru L; Kim H; Chiaravalli M; Boletta A; Qian F; Guggino WB
    J Biol Chem; 2014 Mar; 289(10):6404-6414. PubMed ID: 24459142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystin-2 induces a conformational change in polycystin-1.
    Oatley P; Talukder MM; Stewart AP; Sandford R; Edwardson JM
    Biochemistry; 2013 Aug; 52(31):5280-7. PubMed ID: 23848298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystin-1, the product of the polycystic kidney disease gene PKD1, is post-translationally modified by palmitoylation.
    Roy K; Marin EP
    Mol Biol Rep; 2018 Oct; 45(5):1515-1521. PubMed ID: 30073588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The heteromeric PC-1/PC-2 polycystin complex is activated by the PC-1 N-terminus.
    Ha K; Nobuhara M; Wang Q; Walker RV; Qian F; Schartner C; Cao E; Delling M
    Elife; 2020 Nov; 9():. PubMed ID: 33164752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly synthesized polycystin-1 takes different trafficking pathways to the apical and ciliary membranes.
    Gilder AL; Chapin HC; Padovano V; Hueschen CL; Rajendran V; Caplan MJ
    Traffic; 2018 Dec; 19(12):933-945. PubMed ID: 30125442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of tethered agonist-mediated signaling by polycystin-1.
    Pawnikar S; Magenheimer BS; Munoz EN; Maser RL; Miao Y
    Proc Natl Acad Sci U S A; 2022 May; 119(19):e2113786119. PubMed ID: 35522707
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.